Low-cost generation of Good Manufacturing Practice–grade CD19-specific chimeric antigen receptor–expressing T cells using piggyBac gene transfer and patient-derived materials-Reference-Cited by-同舟云学术

Low-cost generation of Good Manufacturing Practice–grade CD19-specific chimeric antigen receptor–expressing T cells using piggyBac gene transfer and patient-derived materials

Published:2015-09 Issue:9 Volume:17 Page:1251-1267
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Ramanayake Saumya,Bilmon Ian,Bishop David,Dubosq Ming-Celine,Blyth Emily,Clancy Leighton,Gottlieb David,Micklethwaite Kenneth

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference26 articles.

1. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

3. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol,2015

4. Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system;Singh;Cancer Res,2008

5. Transposon mutagenesis of baculoviruses: analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses;Cary;Virology,1989

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Good manufacturing practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia;Frontiers in Immunology;2024-08-13

2. Application of CAR-T cell therapy targeting mesothelin in solid tumor treatment;Discover Oncology;2024-07-18

3. Improving access to gene therapy for rare diseases;Disease Models & Mechanisms;2024-04-19

4. Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy;Molecular Oncology;2024-03-08

5. CAR-T Cells – Main Steps for Obtaining a Proper “Live Drug” Adoptive Therapy;South East European Journal of Immunology;2024-01-23